The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 35 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Prostatic Neoplasms  [Clear All Filters]
2022
Kocic, G., Hadzi-Djokic J., Colic M., Veljkovic A., Tomovic K., Roumeliotis S., et al. (2022).  The Role of Nucleases Cleaving TLR3, TLR7/8 and TLR9 Ligands, Dicer RNase and miRNA/piRNA Proteins in Functional Adaptation to the Immune Escape and Xenophagy of Prostate Cancer Tissue.. Int J Mol Sci. 24(1), 
2019
Soldatos, T. G., Iakovou I., & Sachpekidis C. (2019).  Retrospective Toxicological Profiling of Radium-223 Dichloride for the Treatment of Bone Metastases in Prostate Cancer Using Adverse Event Data.. Medicina (Kaunas). 55(5), 
2017
Ahmed, K., Hatzimouratidis K., & Muneer A. (2017).  Male Sexual Dysfunction and Hypogonadism Guidelines for the Aging Male.. Eur Urol Focus. 3(4-5), 514-516.
Salonia, A., Adaikan G., Buvat J., Carrier S., El-Meliegy A., Hatzimouratidis K., et al. (2017).  Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).. J Sex Med. 14(3), 285-296.
Salonia, A., Adaikan G., Buvat J., Carrier S., El-Meliegy A., Hatzimouratidis K., et al. (2017).  Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).. J Sex Med. 14(3), 297-315.
2016
Sakai, M., Martinez-Arguelles D. B., Aprikian A. G., Magliocco A. M., & Papadopoulos V. (2016).  De novo steroid biosynthesis in human prostate cell lines and biopsies.. Prostate. 76(6), 575-87.
Khera, M., Adaikan G., Buvat J., Carrier S., El-Meliegy A., Hatzimouratidis K., et al. (2016).  Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).. J Sex Med. 13(12), 1787-1804.
Sountoulides, P., & Obek C. (2016).  The era of active surveillance for low-risk.Prostate cancer is here.. Arch Esp Urol. 69(2), 49-51.
2015
Alexiou, E., Georgoulias P., Valotassiou V., Georgiou E., Fezoulidis I., & Vlychou M. (2015).  Multifocal septic osteomyelitis mimicking skeletal metastatic disease in a patient with prostate cancer.. Hell J Nucl Med. 18(1), 77-8.
2014
Andreou, M., Karaiskos P., Kordolaimi S., Koutsouveli E., Sandilos P., Dimitriou P., et al. (2014).  Anatomy- vs. fluence-based planning for prostate cancer treatments using VMAT.. Phys Med. 30(2), 202-8.
Mavroidis, P., Milickovic N., Cruz W. F., Tselis N., Karabis A., Stathakis S., et al. (2014).  Comparison of different fractionation schedules toward a single fraction in high-dose-rate brachytherapy as monotherapy for low-risk prostate cancer using 3-dimensional radiobiological models.. Int J Radiat Oncol Biol Phys. 88(1), 216-23.
Sountoulides, P., & Moutzouris G. (2014).  Prostate-specific antigen screening, why have the guidelines changed?. Expert Rev Anticancer Ther. 14(11), 1277-81.
2013
Ferraldeschi, R., Pezaro C., Karavasilis V., & de Bono J. (2013).  Abiraterone and novel antiandrogens: overcoming castration resistance in prostate cancer.. Annu Rev Med. 64, 1-13.
Papaioannou, M., Söderholm A. A., Hong W., Dai Y., Roediger J., Roell D., et al. (2013).  Computational and functional analysis of the androgen receptor antagonist atraric acid and its derivatives.. Anticancer Agents Med Chem. 13(5), 801-10.
Briasoulis, E., Aravantinos G., Kouvatseas G., Pappas P., Biziota E., Sainis I., et al. (2013).  Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.. BMC Cancer. 13, 263.
Yu, Y. P., Ding Y., Chen R., Liao S. G., Ren B-G., Michalopoulos A., et al. (2013).  Whole-genome methylation sequencing reveals distinct impact of differential methylations on gene transcription in prostate cancer.. Am J Pathol. 183(6), 1960-70.
2012
Sountoulides, P., Theodosiou A., & Finazzi-Agró E. (2012).  The current role of high-intensity focused ultrasound for the management of radiation-recurrent prostate cancer.. Expert Rev Med Devices. 9(4), 401-8.
Panteliou, S. D., Tzortzis V., Anagnostopoulos G. T., Sunaric M. M., Sarris J., Hatzimouratidis K., et al. (2012).  Development of a new optical device and its feasibility in prostate cancer detection.. Urol Int. 89(3), 290-5.
Toulis, K. A., Goulis D. G., Msaouel P., & Koutsilieris M. (2012).  Dexamethasone plus somatostatin-analog manipulation as bone metastasis microenvironment-targeting therapy for the treatment of castration-resistant prostate cancer: a meta-analysis of uncontrolled studies.. Anticancer Res. 32(8), 3283-9.
2011
Bantis, A., Zissimopoulos A., Sountoulides P., Kalaitzis C., Giannakopoulos S., Deftereos S., et al. (2011).  Bisphosphonate-induced osteonecrosis of the jaw in patients with bone metastatic, hormone-sensitive prostate cancer. Risk factors and prevention strategies.. Tumori. 97(4), 479-83.
2010
Molife, L. R., Fong P. C., Paccagnella L., Reid A. H. M., Shaw H. M., Vidal L., et al. (2010).  The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study.. Br J Cancer. 103(3), 332-9.
Papaioannou, M., Schleich S., Roell D., Schubert U., Tanner T., Claessens F., et al. (2010).  NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth.. Invest New Drugs. 28(6), 729-43.
Molife, L. R., Attard G., Fong P. C., Karavasilis V., Reid A. H. M., Patterson S., et al. (2010).  Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC).. Ann Oncol. 21(1), 109-13.
Katsanos, K. H., Briasoulis E., Tsekeris P., Batistatou A., Bai M., Tolis C., et al. (2010).  Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis.. J Exp Clin Cancer Res. 29, 68.
Montorsi, F., Adaikan G., Becher E., Giuliano F., Khoury S., Lue T. F., et al. (2010).  Summary of the recommendations on sexual dysfunctions in men.. J Sex Med. 7(11), 3572-88.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.